KPTI
Karyopharm Therapeutics Inc
0.8022$
-7.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41,443.8% | 43,980.9% | 35,416.2% | 770,666.7% | 841,233.3% | 2,270.7% | 413.2% | 224.9% | 15,241.4% | 18,878.6% | 24,499.4% | 279.3% | 7.7% | 7.7% | 4.5% | 1.2% | 2.1% | 3.0% | 4.0% | 5.0% | 1.6% | 0.6% | 3.0% | 2.4% | 2.7% | 5.6% | 3.5% | 3.2% | 2.5% | 4.6% | 6.0% | 3.6% | 3.4% | 4.4% | 4.3% | 2.8% | 4.8% | 4.4% | 3.9% | 3.2% | 4.1% | |
| -41,343.8% | -43,880.9% | -35,316.2% | -770,566.7% | -841,233.3% | -2,170.7% | -313.2% | -124.9% | -15,141.4% | -18,778.6% | -24,399.4% | -179.3% | 92.3% | 92.3% | 95.5% | 98.8% | 97.9% | 97.0% | 96.0% | 95.0% | 98.4% | 99.4% | 97.0% | 97.6% | 97.3% | 94.4% | 96.5% | 96.8% | 97.5% | 95.4% | 94.0% | 96.4% | 96.6% | 95.6% | 95.7% | 97.2% | 95.2% | 95.6% | 96.1% | 96.8% | 95.9% | |
| 41,443.8% | 43,980.9% | 35,416.2% | 770,666.7% | 841,233.3% | 2,270.7% | 413.2% | 224.9% | 15,241.4% | 18,878.6% | 24,499.4% | 279.3% | 199.8% | 174.5% | 187.4% | 127.1% | 173.6% | 105.9% | 159.3% | 150.4% | 121.5% | 34.8% | 88.2% | 111.7% | 86.8% | 92.1% | 83.6% | 83.8% | 98.7% | 116.5% | 106.7% | 89.5% | 93.2% | 109.0% | 115.3% | 86.4% | 69.3% | 81.2% | 96.3% | 89.6% | 83.2% | |
| 12,285.4% | 13,917.0% | 9,211.8% | 221,166.7% | 193,933.3% | 401.1% | 76.2% | 47.7% | 5,425.1% | 9,112.1% | 17,485.8% | 259.8% | 192.2% | 156.9% | 169.1% | 92.0% | 145.2% | 87.4% | 161.9% | 161.6% | 93.1% | 27.4% | 81.3% | 94.1% | 95.9% | 103.2% | 92.8% | 91.8% | 85.5% | 90.9% | 89.2% | 72.6% | 71.2% | 89.0% | 91.1% | 75.1% | 60.4% | 66.8% | 76.1% | 77.5% | 69.6% | |
| 53,729.2% | 57,897.9% | 44,627.9% | 991,833.3% | 1,035,166.7% | 2,671.8% | 489.4% | 272.6% | 20,666.5% | 27,990.8% | 41,985.2% | 539.1% | 391.9% | 331.4% | 356.6% | 219.1% | 318.8% | 202.6% | 321.2% | 312.0% | 214.7% | 62.2% | 169.6% | 205.8% | 182.6% | 195.3% | 176.4% | 175.5% | 184.3% | 207.4% | 195.9% | 162.1% | 164.4% | 198.1% | 206.5% | 161.5% | 129.8% | 148.0% | 172.4% | 164.1% | 152.0% | |
| -53,629.2% | -57,797.9% | -44,527.9% | -991,733.3% | -1,035,166.7% | -2,571.8% | -389.4% | -172.6% | -20,566.5% | -27,890.8% | -41,885.2% | -439.1% | -299.7% | -239.1% | -261.1% | -120.3% | -220.8% | -105.6% | -225.2% | -217.0% | -116.2% | 37.2% | -72.6% | -108.1% | -85.3% | -100.9% | -79.8% | -78.7% | -86.8% | -112.0% | -101.9% | -65.7% | -67.8% | -102.4% | -110.8% | -64.3% | -34.6% | -52.4% | -76.3% | -67.4% | -56.2% | |
| 660.4% | 785.1% | 566.2% | 12,766.7% | 14,266.7% | 27.4% | 5.0% | 3.3% | 454.0% | 1,210.2% | 1,934.2% | 32.5% | 23.5% | 35.7% | 35.9% | 20.2% | 31.9% | 20.1% | 21.9% | 22.1% | 21.3% | 6.3% | 14.0% | 15.9% | 16.9% | 17.5% | 14.9% | 15.4% | 16.9% | 18.4% | 17.8% | 20.9% | 29.4% | 36.7% | 36.6% | 29.6% | 25.0% | 37.0% | 35.8% | 39.3% | 33.6% | |
| -52,968.8% | -57,012.8% | -43,961.8% | -978,966.7% | -1,020,900.0% | -2,544.4% | -384.5% | -169.3% | -20,112.6% | -28,249.0% | -42,678.1% | -457.3% | -314.4% | -268.8% | -291.5% | -138.1% | -250.6% | -123.5% | -246.2% | -236.5% | -137.2% | 30.6% | -86.6% | -123.3% | -100.4% | -114.5% | -88.0% | -86.5% | -95.8% | -123.6% | -112.6% | 55.8% | -82.6% | -101.1% | -78.0% | -98.1% | -75.1% | -300.1% | -63.9% | -200.5% | -153.3% | |
| -660.4% | 295.7% | 33.8% | 600.0% | 433.3% | 0.6% | 0.1% | -0.1% | 5.9% | 8.3% | 6.5% | 0.1% | 0.2% | 0.0% | 0.4% | 0.4% | 0.2% | 0.2% | 0.6% | 0.6% | 0.3% | -0.1% | 0.3% | 0.3% | 0.1% | 0.2% | 0.1% | 0.3% | 0.0% | 0.4% | 0.2% | 0.2% | 0.1% | -0.4% | 0.1% | 0.1% | 0.1% | -0.2% | 0.0% | – | – | |
| -52,968.8% | -57,308.5% | -43,995.6% | -979,566.7% | -1,021,333.3% | -2,545.0% | -384.6% | -169.2% | -20,118.4% | -28,257.3% | -42,684.5% | -457.3% | -314.6% | -268.8% | -291.8% | -138.5% | -250.8% | -123.7% | -246.8% | -237.1% | -137.5% | 30.7% | -86.8% | -123.6% | -100.5% | -114.7% | -88.2% | -86.8% | -95.8% | -124.0% | -112.8% | 55.6% | -82.7% | -100.8% | -78.2% | -98.2% | -75.2% | -299.9% | -63.9% | -200.5% | -153.3% | |
| -53,256.3% | -56,629.8% | -44,258.8% | -985,733.3% | -1,029,300.0% | -2,560.5% | -382.8% | -168.4% | -20,033.9% | -26,944.7% | -40,585.8% | -422.2% | -289.1% | -230.3% | -254.2% | -117.2% | -217.6% | -102.6% | -223.3% | -213.3% | -115.4% | 37.0% | -72.2% | -107.1% | -83.0% | -96.6% | -72.4% | -70.9% | -78.7% | -105.0% | -94.6% | 76.9% | -53.1% | -64.2% | -41.2% | -68.3% | -51.2% | -263.0% | -28.0% | -161.2% | -120.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.